Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03283423 · ClinicalTrials.gov registry record · NA
Image-guided Lymphadanectomy in AMIGO
A NA study, sponsored by Brigham and Women's Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT03283423 is a NA study that was terminated before completion, run by Brigham and Women's Hospital. The registered enrollment target is 11 participants.
The verdict
NCT03283423, a NA study, was terminated before completion, sponsored by Brigham and Women's Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
To perform image-guided laparoscopic intra-abdominal lymph node biopsy with goal of minimizing surgical risk and improving accuracy of biopsy.
Interventions
- DEVICE Image-guided Lymphadanectomy in AMIGO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2018-10-25 |
| Est. Completion | 2020-03-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03283423
The ClinicalTrials.gov registry entry for NCT03283423 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Image-guided Lymphadanectomy in AMIGO is the first listed.
NCT03283423 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03283423 about?
NCT03283423 is a clinical study titled "Image-guided Lymphadanectomy in AMIGO". To perform image-guided laparoscopic intra-abdominal lymph node biopsy with goal of minimizing surgical risk and improving accuracy of biopsy.
What is the current status of trial NCT03283423?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2018-10-25. Estimated completion is 2020-03-20.
What interventions are being tested in trial NCT03283423?
The interventions under investigation include: Image-guided Lymphadanectomy in AMIGO (DEVICE).
Who is sponsoring clinical trial NCT03283423?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.